Display options
Cite
Kiessling MK, Curioni-Fontecedro A, Samaras P, et al. Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma. PLoS One. 2017;12(1):e0170851doi: 10.1371/journal.pone.0170851.
Kiessling, M. K., Curioni-Fontecedro, A., Samaras, P., Lang, S., Scharl, M., Aguzzi, A., Oldridge, D. A., Maris, J. M., & Rogler, G. (2017). Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma. PloS one, 12(1), e0170851. https://doi.org/10.1371/journal.pone.0170851
Kiessling, Michael K, et al. "Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma." PloS one vol. 12,1 (2017): e0170851. doi: https://doi.org/10.1371/journal.pone.0170851
Kiessling MK, Curioni-Fontecedro A, Samaras P, Lang S, Scharl M, Aguzzi A, Oldridge DA, Maris JM, Rogler G. Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma. PLoS One. 2017 Jan 20;12(1):e0170851. doi: 10.1371/journal.pone.0170851. eCollection 2017. PMID: 28107499; PMCID: PMC5249053.
Copy Download .nbib Format: NLM
Share it on

PLoS One. 2017 Jan 20;12(1):e0170851. doi: 10.1371/journal.pone.0170851. eCollection 2017.

Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma.

PloS one

Michael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, Silvia Lang, Michael Scharl, Adriano Aguzzi, Derek A Oldridge, John M Maris, Gerhard Rogler

PMID: 28107499 PMCID: PMC5249053 DOI: 10.1371/journal.pone.0170851

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0147682.].

References

  1. PLoS One. 2016 Jan 28;11(1):e0147682 - PubMed

Publication Types

Grant support